{"id":"W2947303166","doi":"10.1200/jco.2019.37.15_suppl.6513","title":"Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Food and drug administration; Cancer drugs; Clinical Oncology; Cancer; Randomized controlled trial; Internal medicine; Drug; Clinical research; Oncology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008328473,0.0002601274,0.000750423,0.002317524,0.0003498691,0.001033981,0.0002849936,0.0004947659,0.008546884],"category_scores_gemma":[0.01729671,0.0001318844,0.001175186,0.003788458,0.0003212331,0.0007709537,0.0005185703,0.0009835651,0.001223167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001401933,"about_ca_system_score_gemma":0.001933809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001211301,"about_ca_topic_score_gemma":0.003301435,"domain_scores_codex":[0.9956377,0.001718586,0.0007568905,0.0004663868,0.001176411,0.0002439958],"domain_scores_gemma":[0.9812244,0.008634707,0.006741091,0.0004764452,0.001847688,0.001075702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02423111,0.0004943297,0.3321281,0.01057978,0.003194504,0.0001552117,0.0001620322,0.001649564,0.001633278,0.004209748,0.09725878,0.5243036],"study_design_scores_gemma":[0.007186425,0.009296604,0.6566094,0.004574991,0.006011043,0.001409448,0.0003332032,0.002967288,0.002407519,0.006397117,0.3026855,0.0001214189],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4452113,0.3022591,0.005377796,0.01171781,0.001179824,0.003822473,0.1331926,0.0004661261,0.09677299],"genre_scores_gemma":[0.9252684,0.02391368,0.004964223,0.003370059,0.000540427,0.001365496,0.03597265,0.00006406328,0.004541009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008546884,"threshold_uncertainty_score":0.04404569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4202416281277462,"score_gpt":0.5449675164172438,"score_spread":0.1247258882894977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}